Ayurvedic management for gout
Not Applicable
- Conditions
- Health Condition 1: M109- Gout, unspecified
- Registration Number
- CTRI/2019/07/019972
- Lead Sponsor
- Dr Rukhsar Sheikh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of either gender
Patients with age 18 to 70 years
Serum uric acid level >7 mg / dl for men and > 6 mg / dl for women
Chronic cases of gout ( more than 1 year )
Exclusion Criteria
Immunocompromised patients or patients on immunosuppressive drugs
Patients suffering from life threatening diseases
Pregnant women and lactating mother
Patients with k/c/o hypersensitivity of any drug
Patients suffering from chronic kidney diseases or end stage renal diseases and requiring dialysis
Patients taking diuretics, aspirin, ethambutol, pyrazinamide, cyclosporine, cytotoxic drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patoladi kwatha more effective in management of vaatarakta than febuxostatTimepoint: once in a month for three months
- Secondary Outcome Measures
Name Time Method The effect of patoladi kwatha will be less effective as compared to febuxostat on vaataraktaTimepoint: once in a month for three months